You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Drugs Containing Excipient (Inactive Ingredient) PPG-11 STEARYL ETHER


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing PPG-11 STEARYL ETHER excipient

PPG-11 STEARYL ETHER Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for PPG-11 Stearyl Ether

Introduction to PPG-11 Stearyl Ether

PPG-11 Stearyl Ether is a polypropylene glycol ether of stearyl alcohol, commonly used as a skin-conditioning agent and emollient in cosmetic and pharmaceutical formulations. Understanding its market dynamics and financial trajectory is crucial for stakeholders in the pharmaceutical and cosmetic industries.

Function and Safety Assessment

PPG-11 Stearyl Ether functions primarily as a skin-conditioning agent, enhancing the moisturizing and emollient properties of products. The Cosmetic Ingredient Review (CIR) Expert Panel has assessed its safety, concluding that it is safe for use in cosmetics at concentrations up to 5%[2][3].

Market Size and Growth

The global market for PPG-11 Stearyl Ether is part of the broader pharmaceutical excipients market, which was valued at $9.2 billion in 2023 and is expected to grow to $12.4 billion by 2029, with a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029[4].

While specific figures for the PPG-11 Stearyl Ether market are not widely available, the growth in demand for innovative excipients driven by the rise in chronic diseases and the need for more effective drug formulations suggests a positive outlook. The market for PPG-11 Stearyl Ether is expected to grow, albeit at a rate that aligns with the overall excipients market[5].

Drivers of Demand

Several factors drive the demand for PPG-11 Stearyl Ether:

Increasing Chronic Diseases

The rise in chronic diseases such as diabetes, hypertension, cancer, and HIV necessitates the development of more effective and patient-friendly drug formulations. PPG-11 Stearyl Ether, with its skin-conditioning properties, is valuable in topical and transdermal drug delivery systems[4].

Advancements in Drug Formulations

The need to enhance the solubility, bioavailability, and stability of active pharmaceutical ingredients (APIs) drives innovation in excipient development. PPG-11 Stearyl Ether's role in improving the delivery and efficacy of drugs makes it a sought-after component[4].

Cosmetic Industry Demand

In addition to pharmaceutical applications, the cosmetic industry's demand for emollients and skin-conditioning agents also contributes to the market growth of PPG-11 Stearyl Ether. Its use in antiperspirants, deodorants, and other personal care products is significant[1].

Concentration and Frequency of Use

The concentration and frequency of use of PPG-11 Stearyl Ether have evolved over time. Historically, it was used at concentrations up to 10%, but recent data indicates a decrease to a maximum of 5% in cosmetic formulations. The frequency of use has remained relatively stable, with 16 reported uses in 2022[2].

Regulatory and Safety Considerations

The safety assessment of PPG-11 Stearyl Ether is well-documented. The CIR Expert Panel has concluded that it is safe for use in cosmetics at the specified concentrations. However, there are restrictions and guidelines:

  • EWG VERIFIED Products: These products cannot contain PPG-11 Stearyl Ether without adequate substantiation[1].
  • Concentration Limits: The maximum concentration of use has been reduced to 5% to ensure safety[2][3].

Environmental and Toxicological Concerns

While PPG-11 Stearyl Ether is not suspected to be persistent or bioaccumulative, it is suspected to be an environmental toxin. This aspect is crucial for manufacturers and users to consider in their environmental impact assessments[1].

Market Players and Innovation

Leading companies in the pharmaceutical excipients market, such as ADM, BASF SE, Roquette Frères, Ashland Global, and Croda International Plc, play a significant role in driving innovation and sustainability in excipient development. These companies leverage their expertise and resources to ensure the continuous improvement and safety of ingredients like PPG-11 Stearyl Ether[4].

Financial Trajectory

The financial trajectory of PPG-11 Stearyl Ether is closely tied to the overall growth of the pharmaceutical excipients market. Here are some key financial indicators:

  • Market Growth: The global market for pharmaceutical excipients is expected to grow from $9.7 billion in 2024 to $12.4 billion by 2029, indicating a positive financial outlook for PPG-11 Stearyl Ether as part of this market[4].
  • Revenue Projections: While specific revenue projections for PPG-11 Stearyl Ether are not available, the overall market growth suggests that revenues will increase in line with the broader excipients market[5].

Key Takeaways

  • Safety and Regulatory Compliance: PPG-11 Stearyl Ether is considered safe for use in cosmetics at concentrations up to 5%, with ongoing regulatory oversight.
  • Market Growth: The market is driven by the rise in chronic diseases and the need for innovative drug formulations.
  • Environmental Considerations: While not persistent or bioaccumulative, it is suspected to be an environmental toxin.
  • Innovation and Sustainability: Leading companies are driving innovation and sustainability in excipient development.

FAQs

Q1: What is PPG-11 Stearyl Ether used for? PPG-11 Stearyl Ether is used as a skin-conditioning agent and emollient in cosmetic and pharmaceutical formulations.

Q2: Is PPG-11 Stearyl Ether safe for use? Yes, it is considered safe for use in cosmetics at concentrations up to 5% according to the Cosmetic Ingredient Review (CIR) Expert Panel[2][3].

Q3: What are the environmental concerns associated with PPG-11 Stearyl Ether? It is suspected to be an environmental toxin, although it is not persistent or bioaccumulative[1].

Q4: How is the market for PPG-11 Stearyl Ether expected to grow? The market is expected to grow in line with the broader pharmaceutical excipients market, driven by the rise in chronic diseases and the need for innovative drug formulations[4].

Q5: Which companies are key players in the development of PPG-11 Stearyl Ether? Leading companies such as ADM, BASF SE, Roquette Frères, Ashland Global, and Croda International Plc are pivotal in driving innovation and sustainability in excipient development[4].

Sources

  1. EWG Skin Deep® | What is PPG-11 STEARYL ETHER
  2. Safety Assessment of PPG-11 and PPG-15 Stearyl Ether as Used in Cosmetics
  3. Final report on the safety assessment of PPG-11 and PPG-15 stearyl ether
  4. Understanding the Future of Pharmaceutical Excipients
  5. PPG-11 Stearyl Ether - Market, Report Size, Worth, Revenue

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.